Thongchai, K.; Chuysinuan, P.; Thanyacharoen, T.; Techasakul, S.; Ummartyotin, S. Characterization, Release, and Antioxidant Activity of Caffeic Acid-Loaded Collagen and Chitosan Hydrogel Composites. J. Mater. Res. 2020, 9, 6512-6520.

28 Dec 2020
0
0

Thongchai, K.; Chuysinuan, P.; Thanyacharoen, T.; Techasakul, S.; Ummartyotin, S. Characterization, Release, and Antioxidant Activity of Caffeic Acid-Loaded Collagen and Chitosan Hydrogel Composites. J. Mater. Res. 2020, 9, 6512-6520.

Tags

Share this

Related Posts

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810
01 Oct 2016
0

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More